• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预防手术治疗后鼻息肉复发的治疗策略:成纤维细胞生长抑制的最新进展及体外研究

Therapeutic Strategies to Prevent the Recurrence of Nasal Polyps after Surgical Treatment: An Update and In Vitro Study on Growth Inhibition of Fibroblasts.

作者信息

Rizzi Angela, Gammeri Luca, Cordiano Raffaele, Valentini Mariagrazia, Centrone Michele, Marrone Sabino, Inchingolo Riccardo, Lohmeyer Franziska Michaela, Cavaliere Carlo, Ria Francesco, Cadoni Gabriella, Gangemi Sebastiano, Nucera Eleonora

机构信息

UOSD Allergologia e Immunologia Clinica, Dipartimento Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Department of Clinical and Experimental Medicine, School and Operative Unit of Allergy and Clinical Immunology, University of Messina, 98125 Messina, Italy.

出版信息

J Clin Med. 2023 Apr 13;12(8):2841. doi: 10.3390/jcm12082841.

DOI:10.3390/jcm12082841
PMID:37109177
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10142691/
Abstract

Chronic rhinosinusitis with nasal polyps (CRSwNP) is the most bothersome phenotype of chronic rhinosinusitis, which is typically characterized by a Type 2 inflammatory reaction, comorbidities and high rates of nasal polyp recurrence, causing severe impact on quality of life. Nasal polyp recurrence rates, defined as the number of patients undergoing revision endoscopic sinus surgery, are 20% within a 5 year period after surgery. The cornerstone of CRSwNP management consists of anti-inflammatory treatment with local corticosteroids. We performed a literature review regarding the therapeutic strategies used to prevent nasal polyp recurrence after surgical treatment. Finally, we report an in vitro study evaluating the efficacy of lysine-acetylsalicylic acid and other non-steroidal anti-inflammatory drugs (ketoprofen and diclofenac) on the proliferation of fibroblasts, obtained from nasal polyp tissue samples. Our study demonstrates that diclofenac, even more so than lysine-acetylsalicylic acid, significantly inhibits fibroblast proliferation and could be considered a valid therapeutic strategy in preventing CRSwNP recurrence.

摘要

伴有鼻息肉的慢性鼻-鼻窦炎(CRSwNP)是慢性鼻-鼻窦炎最令人困扰的表型,其典型特征为2型炎症反应、合并症以及鼻息肉高复发率,对生活质量造成严重影响。鼻息肉复发率定义为接受内镜鼻窦修正手术的患者数量,术后5年内的复发率为20%。CRSwNP治疗的基石包括局部使用糖皮质激素进行抗炎治疗。我们对手术治疗后预防鼻息肉复发所采用的治疗策略进行了文献综述。最后,我们报告了一项体外研究,评估赖氨酸-乙酰水杨酸及其他非甾体抗炎药(酮洛芬和双氯芬酸)对从鼻息肉组织样本中获取的成纤维细胞增殖的影响。我们的研究表明,双氯芬酸比赖氨酸-乙酰水杨酸更能显著抑制成纤维细胞增殖,可被视为预防CRSwNP复发的有效治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c40/10142691/2167024cf1dd/jcm-12-02841-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c40/10142691/e69828832d89/jcm-12-02841-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c40/10142691/1b6d30b6dad9/jcm-12-02841-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c40/10142691/2167024cf1dd/jcm-12-02841-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c40/10142691/e69828832d89/jcm-12-02841-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c40/10142691/1b6d30b6dad9/jcm-12-02841-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c40/10142691/2167024cf1dd/jcm-12-02841-g003.jpg

相似文献

1
Therapeutic Strategies to Prevent the Recurrence of Nasal Polyps after Surgical Treatment: An Update and In Vitro Study on Growth Inhibition of Fibroblasts.预防手术治疗后鼻息肉复发的治疗策略:成纤维细胞生长抑制的最新进展及体外研究
J Clin Med. 2023 Apr 13;12(8):2841. doi: 10.3390/jcm12082841.
2
State of the Art Medical Management of Nasal Polyps.鼻息肉的最新医学管理
Am J Rhinol Allergy. 2023 Mar;37(2):153-161. doi: 10.1177/19458924221145256.
3
Twelve-year follow-up study after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis.慢性鼻-鼻窦炎伴鼻息肉患者内镜鼻窦手术后的12年随访研究
Clin Transl Allergy. 2019 Jun 14;9:30. doi: 10.1186/s13601-019-0269-4. eCollection 2019.
4
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.度普利尤单抗治疗伴有鼻息肉的重度慢性鼻-鼻窦炎患者的疗效和安全性(LIBERTY NP SINUS-24 和 LIBERTY NP SINUS-52):两项多中心、随机、双盲、安慰剂对照、平行分组 3 期临床试验的结果。
Lancet. 2019 Nov 2;394(10209):1638-1650. doi: 10.1016/S0140-6736(19)31881-1. Epub 2019 Sep 19.
5
The Effect of the Premedication with Systemic Corticosteroids and Antibiotics on Inflammation and Intraoperative Bleeding During Sinonasal Endoscopic Surgery for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).全身皮质类固醇和抗生素预处理对慢性鼻-鼻窦炎伴鼻息肉(CRSwNP)鼻内镜手术中炎症和术中出血的影响。
J Craniofac Surg. 2022 Jun 1;33(4):e405-e408. doi: 10.1097/SCS.0000000000008285. Epub 2022 Jan 28.
6
Topical steroids for nasal polyps.用于鼻息肉的局部用类固醇
Cochrane Database Syst Rev. 2012 Dec 12;12:CD006549. doi: 10.1002/14651858.CD006549.pub2.
7
Differences in Expression of Inflammatory Mediator in Mucosal and Polyp Tissue between Chronic Rhinosinusitis and Recurrent Chronic Rhinosinusitis.慢性鼻窦炎与复发性慢性鼻窦炎患者黏膜及息肉组织中炎症介质表达的差异
Open Access Maced J Med Sci. 2019 May 31;7(11):1733-1738. doi: 10.3889/oamjms.2019.341. eCollection 2019 Jun 15.
8
Vitamin D decreases the secretion of eotaxin and RANTES in nasal polyp fibroblasts derived from Taiwanese patients with chronic rhinosinusitis with nasal polyps.维生素D可减少源自台湾慢性鼻-鼻窦炎伴鼻息肉患者的鼻息肉成纤维细胞中嗜酸性粒细胞趋化因子和调节激活正常T细胞表达和分泌的趋化因子的分泌。
Kaohsiung J Med Sci. 2015 Feb;31(2):63-9. doi: 10.1016/j.kjms.2014.11.011. Epub 2014 Dec 17.
9
Central compartment atopic disease: outcomes compared with other subtypes of chronic rhinosinusitis with nasal polyps.中央型特应性疾病:与慢性鼻-鼻窦炎伴鼻息肉其他亚型的结局比较
Int Forum Allergy Rhinol. 2021 Nov;11(11):1549-1556. doi: 10.1002/alr.22819. Epub 2021 Jun 2.
10
Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis.鼻息肉型慢性鼻-鼻窦炎内镜鼻窦手术后息肉复发的患病率
Laryngoscope. 2017 Mar;127(3):550-555. doi: 10.1002/lary.26391. Epub 2016 Nov 12.

引用本文的文献

1
Circulating Exosomal microRNA Profiles Associated with Risk of Postoperative Recurrence in Chronic Rhinosinusitis with Nasal Polyps.与伴鼻息肉慢性鼻窦炎术后复发风险相关的循环外泌体微小RNA谱
J Inflamm Res. 2024 Aug 23;17:5619-5631. doi: 10.2147/JIR.S472963. eCollection 2024.
2
The Inhibition Effect and Mechanism of Staurosporine Isolated from sp. SNC087 Strain on Nasal Polyp.从 sp. SNC087 菌株中分离出的星形孢菌素对鼻息肉的抑制作用及机制。
Mar Drugs. 2024 Jan 11;22(1):39. doi: 10.3390/md22010039.
3
Biologics for Chronic Rhinosinusitis-A Modern Option for Therapy.

本文引用的文献

1
Development of an intranasal formulation containing indomethacin and xylometazoline for rhinosinusitis treatment.开发一种含有吲哚美辛和麻黄碱的鼻内制剂,用于治疗鼻窦炎。
Eur Rev Med Pharmacol Sci. 2022 Dec;26(2 Suppl):65-71. doi: 10.26355/eurrev_202212_30486.
2
Nasal irrigation with licorice extract (Glycyrrhiza glabra) in treating nasal polyps by reducing fibroblast differentiation and extracellular matrix production in TGF-β1-stimulated nasal polyp-derived fibroblasts by inhibiting the MAPK/ERK-1/2 pathway - an in vitro and in clinic study.甘草提取物(Glycyrrhiza glabra)经鼻冲洗治疗鼻息肉的研究:通过抑制 MAPK/ERK-1/2 通路减少 TGF-β1 刺激的鼻息肉衍生成纤维细胞的分化和细胞外基质的产生——一项体外和临床研究。
BMC Complement Med Ther. 2022 Nov 29;22(1):313. doi: 10.1186/s12906-022-03791-y.
3
用于慢性鼻-鼻窦炎的生物制剂——一种现代治疗选择
Life (Basel). 2023 Nov 5;13(11):2165. doi: 10.3390/life13112165.
A safety investigation into topical effects of naproxen sodium on nasal epithelial cells and potential toxicity in local application.一项关于局部应用萘普生钠对鼻上皮细胞的局部作用和潜在毒性的安全性调查。
Am J Otolaryngol. 2023 Jan-Feb;44(1):103689. doi: 10.1016/j.amjoto.2022.103689. Epub 2022 Nov 18.
4
Real-world-effectiveness of biological treatment for severe chronic rhinosinusitis with nasal polyps.生物治疗严重慢性鼻-鼻窦炎伴鼻息肉的真实世界疗效。
Rhinology. 2022 Dec 1;60(6):435-443. doi: 10.4193/Rhin22.129.
5
Asian herbal medicine and chronic urticaria: which are the therapeutic perspectives?亚洲草药与慢性荨麻疹:治疗前景如何?
Nat Prod Res. 2023 Jun;37(11):1917-1934. doi: 10.1080/14786419.2022.2122055. Epub 2022 Sep 12.
6
Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study.美泊利珠单抗改善重度哮喘患者慢性鼻-鼻窦炎伴鼻息肉的预后:一项多中心真实世界研究
J Pers Med. 2022 Aug 10;12(8):1304. doi: 10.3390/jpm12081304.
7
Biological Therapy of Severe Asthma and Nasal Polyps.重度哮喘和鼻息肉的生物治疗
J Pers Med. 2022 Jun 16;12(6):976. doi: 10.3390/jpm12060976.
8
The Nose as a Route for Therapy: Part 1. Pharmacotherapy.作为治疗途径的鼻子:第一部分。药物治疗。
Front Allergy. 2021 Feb 22;2:638136. doi: 10.3389/falgy.2021.638136. eCollection 2021.
9
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count.美泊利珠单抗治疗伴有鼻息肉的慢性鼻-鼻窦炎:基于合并症和血嗜酸性粒细胞计数的治疗疗效。
J Allergy Clin Immunol. 2022 May;149(5):1711-1721.e6. doi: 10.1016/j.jaci.2021.10.040. Epub 2022 Jan 7.
10
Defining the Efficacy of Omalizumab in Nasal Polyposis: A POLYP 1 and POLYP 2 Subgroup Analysis.奥马珠单抗治疗鼻息肉的疗效评估:POLYP1 和 POLYP2 亚组分析。
Am J Rhinol Allergy. 2022 Jan;36(1):135-141. doi: 10.1177/19458924211030486. Epub 2021 Aug 12.